<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.oncnursingnews.com/view/glp-1-ras-linked-to-lower-hr-breast-cancer-risk-and-improved-survival</loc><lastmod>2026-06-03T17:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T17:00:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nursing-guide-to-managing-lorlatinib-in-alk-nsclc-7-year-crown-insights</loc><lastmod>2026-06-03T13:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-oral-nilotinib-tablets-for-ph-cml</loc><lastmod>2026-06-02T18:09:45.064Z</lastmod><news:news><news:publication_date>2026-06-02T18:09:45.064Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Oral Nilotinib Tablets for Ph+ CML ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ascent-04-biomarker-analysis-favors-sacituzumab-govitecan-in-1l-tnbc</loc><lastmod>2026-06-02T16:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T16:00:00Z</news:publication_date>
        <news:title><![CDATA[ASCENT-04: Biomarker Analysis Favors Sacituzumab Govitecan in 1L TNBC ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/managing-rash-and-stomatitis-with-daraxonrasib-in-pancreatic-cancer</loc><lastmod>2026-06-02T13:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/stride-based-regimens-plus-tace-improve-pfs-in-embolization-eligible-hcc</loc><lastmod>2026-06-01T21:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T21:00:00Z</news:publication_date>
        <news:title><![CDATA[STRIDE-Based Regimens Plus TACE Improve PFS in Embolization-Eligible HCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ipatasertib-plus-pembrolizumab-boosts-response-in-first-line-r-m-hnscc</loc><lastmod>2026-06-01T18:30:00Z</lastmod><news:news><news:publication_date>2026-06-01T18:30:00Z</news:publication_date>
        <news:title><![CDATA[Ipatasertib Plus Pembrolizumab Boosts Response in First-Line R/M HNSCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/frailty-score-shows-link-to-toxicity-mortality-risk-with-novel-cancer-therapies</loc><lastmod>2026-06-01T16:07:23.200Z</lastmod><news:news><news:publication_date>2026-06-01T16:07:23.200Z</news:publication_date>
        <news:title><![CDATA[Frailty Score Shows Link to Toxicity, Mortality Risk With Novel Cancer Therapies ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/glp-1-ras-may-boost-survival-lower-iraes-in-patients-on-icis</loc><lastmod>2026-05-31T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-31T18:00:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1 RAs May Boost Survival, Lower irAEs in Patients on ICIs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nursing-strategies-to-combat-food-insecurity-in-metastatic-breast-cancer</loc><lastmod>2026-05-31T13:50:29.920Z</lastmod><news:news><news:publication_date>2026-05-31T13:50:29.920Z</news:publication_date>
        <news:title><![CDATA[Nursing Strategies to Combat Food Insecurity in Metastatic Breast Cancer ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/precision-prophylaxis-managing-diverse-adc-safety-profiles-at-asco-2026</loc><lastmod>2026-05-30T23:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Precision Prophylaxis: Managing Diverse ADC Safety Profiles at ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/pembrolizumab-improves-7-year-os-in-early-stage-tnbc-keynote-522-final-data</loc><lastmod>2026-05-30T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Pembrolizumab Improves 7-Year OS in Early-Stage TNBC: KEYNOTE-522 Final Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/standardizing-chemotherapy-safety-navigating-the-expansion-of-non-traditional-oncology-care-delivery</loc><lastmod>2026-05-29T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Standardizing Chemotherapy Safety: Navigating the Expansion of Non-Traditional Oncology Care Delivery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/discussing-erectile-dysfunction-after-prostate-cancer-treatment</loc><lastmod>2026-05-29T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Discussing Erectile Dysfunction After Prostate Cancer Treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/the-moonlight-shift-dr-maurie-markman-on-oncology-s-hardest-problems</loc><lastmod>2026-05-28T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T20:00:00Z</news:publication_date>
        <news:title><![CDATA[The Moonlight Shift: Dr Maurie Markman on Oncology's Hardest Problems]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/navigating-efficacy-benchmarks-and-real-world-outcomes-in-metastatic-colorectal-cancer</loc><lastmod>2026-05-28T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Navigating Efficacy Benchmarks and Real-World Outcomes in Metastatic Colorectal Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-durvalumab-and-bcg-for-high-risk-nmibc</loc><lastmod>2026-05-28T16:47:16.418Z</lastmod><news:news><news:publication_date>2026-05-28T16:47:16.418Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Durvalumab and BCG for High-Risk NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/imetelstat-demonstrates-survival-benefit-in-r-r-myelofibrosis-vs-real-world-data</loc><lastmod>2026-05-28T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Imetelstat Demonstrates Survival Benefit in R/R Myelofibrosis Vs Real-World Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-pivekimab-sunirine-pvzy-for-bpdcn</loc><lastmod>2026-05-27T19:31:40.984Z</lastmod><news:news><news:publication_date>2026-05-27T19:31:40.984Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Pivekimab Sunirine-pvzy for BPDCN]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/darolutamide-shows-less-cognitive-decline-vs-enzalutamide-in-advanced-prostate-cancer</loc><lastmod>2026-05-27T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Darolutamide Shows Less Cognitive Decline Vs Enzalutamide in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/treating-erectile-dysfunction-post-prostate-cancer-therapy-requires-personalization</loc><lastmod>2026-05-26T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Treating Erectile Dysfunction Post-Prostate Cancer Therapy Requires Personalization ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/glp-1-receptor-agonists-show-promise-in-asco-2026-research</loc><lastmod>2026-05-26T14:35:00Z</lastmod><news:news><news:publication_date>2026-05-26T14:35:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/understanding-the-psychoneurological-symptom-cluster-in-adults-with-hematologic-malignancies</loc><lastmod>2026-05-23T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding the Psychoneurological Symptom Cluster in Adults With Hematologic Malignancies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-datopotamab-deruxtecan-dlnk-for-first-line-metastatic-tnbc</loc><lastmod>2026-05-22T14:30:23.414Z</lastmod><news:news><news:publication_date>2026-05-22T14:30:23.414Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Datopotamab deruxtecan-dlnk for First-Line Metastatic TNBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/accompani-intervention-supports-african-american-families-in-pediatric-cancer-care</loc><lastmod>2026-05-21T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T21:00:00Z</news:publication_date>
        <news:title><![CDATA[ACCOMPANI Intervention Supports African American Families in Pediatric Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/the-multigenerational-nursing-workforce</loc><lastmod>2026-05-21T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T17:00:00Z</news:publication_date>
        <news:title><![CDATA[The Multigenerational Nursing Workforce]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/retifanlimab-plus-chemotherapy-extends-survival-in-advanced-anal-cancer</loc><lastmod>2026-05-19T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Retifanlimab Plus Chemotherapy Extends Survival in Advanced Anal Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/prevention-in-post-treatment-survivorship</loc><lastmod>2026-05-19T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Prevention in Post-Treatment Survivorship]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/redefining-the-nursing-role-in-young-onset-colorectal-cancer</loc><lastmod>2026-05-18T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Redefining the Nursing Role in Young-Onset Colorectal Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ai-tools-may-support-but-not-replace-oncology-nursing-care</loc><lastmod>2026-05-18T15:32:47.701Z</lastmod><news:news><news:publication_date>2026-05-18T15:32:47.701Z</news:publication_date>
        <news:title><![CDATA[AI Tools May Support, But Not Replace, Oncology Nursing Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/exercise-related-cognitive-benefits-may-differ-by-biologic-aging-and-neighborhood-deprivation</loc><lastmod>2026-05-16T19:00:06.131Z</lastmod><news:news><news:publication_date>2026-05-16T19:00:06.131Z</news:publication_date>
        <news:title><![CDATA[Exercise’s Cognitive Benefits in Breast Cancer Survivors May Vary by Aging and Neighborhood Factors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nurse-led-palliative-care-conversations-enhance-hsct-and-car-t-outcomes</loc><lastmod>2026-05-16T16:30:00Z</lastmod><news:news><news:publication_date>2026-05-16T16:30:00Z</news:publication_date>
        <news:title><![CDATA[Nurse-Led Palliative Care Conversations Enhance HSCT and CAR-T Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/dnp-ons-chapter-collaboration-helps-address-oncology-nurse-retention-and-burnout</loc><lastmod>2026-05-16T15:28:07.812Z</lastmod><news:news><news:publication_date>2026-05-16T15:28:07.812Z</news:publication_date>
        <news:title><![CDATA[DNP–ONS Chapter Collaboration Helps Address Oncology Nurse Retention and Burnout ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-grants-dual-approval-for-t-dxd-in-her2-early-breast-cancer</loc><lastmod>2026-05-16T15:24:11.757Z</lastmod><news:news><news:publication_date>2026-05-16T15:24:11.757Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Dual Approval for T-DXd in HER2+ Early Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/progressive-care-model-in-heme-onc-units-boosts-immunotherapy-safety</loc><lastmod>2026-05-15T21:30:00Z</lastmod><news:news><news:publication_date>2026-05-15T21:30:00Z</news:publication_date>
        <news:title><![CDATA[Progressive Care Model in Heme-Onc Units Boosts Immunotherapy Safety]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/new-qi-initiative-boosts-oncology-nurse-confidence-in-triage-of-n-v-d</loc><lastmod>2026-05-15T20:30:00Z</lastmod><news:news><news:publication_date>2026-05-15T20:30:00Z</news:publication_date>
        <news:title><![CDATA[New QI Initiative Boosts Oncology Nurse Confidence in Triage of N/V/D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-atezolizumab-for-ctdna-positive-muscle-invasive-bladder-cancer</loc><lastmod>2026-05-15T17:03:44.226Z</lastmod><news:news><news:publication_date>2026-05-15T17:03:44.226Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Atezolizumab for ctDNA-Positive Muscle-Invasive Bladder Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/antineoplastic-onboarding-boosts-nurse-competency-in-solid-hematologic-oncology</loc><lastmod>2026-05-15T15:52:16.359Z</lastmod><news:news><news:publication_date>2026-05-15T15:52:16.359Z</news:publication_date>
        <news:title><![CDATA[Antineoplastic Onboarding Boosts Nurse Competency in Solid/Hematologic Oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/cipn-persists-years-after-frontline-lymphoma-therapy-study-findings-show</loc><lastmod>2026-05-15T14:56:10.548Z</lastmod><news:news><news:publication_date>2026-05-15T14:56:10.548Z</news:publication_date>
        <news:title><![CDATA[CIPN Persists Years After Frontline Lymphoma Therapy, Study Findings Show]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/gut-microbiome-patterns-influence-fatigue-and-pain-in-melanoma-patients-receiving-icis</loc><lastmod>2026-05-14T22:05:21.948Z</lastmod><news:news><news:publication_date>2026-05-14T22:05:21.948Z</news:publication_date>
        <news:title><![CDATA[Gut Microbiome Patterns Influence Fatigue and Pain in Melanoma Patients Receiving ICIs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/sound-machines-cut-patient-anxiety-in-gynecology-oncology-clinics</loc><lastmod>2026-05-14T19:26:00.489Z</lastmod><news:news><news:publication_date>2026-05-14T19:26:00.489Z</news:publication_date>
        <news:title><![CDATA[Sound Machines Cut Patient Anxiety in Gynecology Oncology Clinics]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/occlusion-rates-low-following-change-in-flush-practice-for-patients-with-cancer</loc><lastmod>2026-05-14T16:28:37.478Z</lastmod><news:news><news:publication_date>2026-05-14T16:28:37.478Z</news:publication_date>
        <news:title><![CDATA[Occlusion Rates Low Following Change in Flush Practice for Patients With Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/jill-winther-bsn-rn-ocn-npd-bc-wins-2026-extraordinary-healer-award</loc><lastmod>2026-05-14T15:38:45.207Z</lastmod><news:news><news:publication_date>2026-05-14T15:38:45.207Z</news:publication_date>
        <news:title><![CDATA[Jill Winther, BSN, RN, OCN, NPD-BC, Wins 2026 Extraordinary Healer® Award]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-oral-decitabine-cedazuridine-and-venetoclax-for-aml</loc><lastmod>2026-05-13T19:54:30.548Z</lastmod><news:news><news:publication_date>2026-05-13T19:54:30.548Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Oral Decitabine/Cedazuridine and Venetoclax for AML]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-sonrotoclax-for-r-r-mantle-cell-lymphoma</loc><lastmod>2026-05-13T19:40:41.023Z</lastmod><news:news><news:publication_date>2026-05-13T19:40:41.023Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Sonrotoclax for R/R Mantle Cell Lymphoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/rural-patients-with-cancer-face-higher-costs-and-care-barriers-acs-can-finds</loc><lastmod>2026-05-13T17:13:29Z</lastmod><news:news><news:publication_date>2026-05-13T17:13:29Z</news:publication_date>
        <news:title><![CDATA[Rural Patients With Cancer Face Higher Costs and Care Barriers, ACS CAN Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ctdna-in-breast-cancer-navigating-the-gap-between-hype-and-clinical-utility</loc><lastmod>2026-05-12T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T20:00:00Z</news:publication_date>
        <news:title><![CDATA[ctDNA in Breast Cancer: Navigating the Gap Between Hype and Clinical Utility]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/icis-linked-to-increased-risk-of-pad-and-amputation-in-patients-with-cancer</loc><lastmod>2026-05-12T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T15:00:00Z</news:publication_date>
        <news:title><![CDATA[ICIs Linked to Increased Risk of PAD and Amputation in Patients With Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/md-anderson-trial-explores-psilocybin-assisted-therapy-for-cancer-mental-health</loc><lastmod>2026-05-11T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-11T20:00:00Z</news:publication_date>
        <news:title><![CDATA[MD Anderson Trial Explores Psilocybin-Assisted Therapy for Cancer Mental Health]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/vepdegestrant-fda-approval-what-to-know-about-the-first-breast-cancer-protac</loc><lastmod>2026-05-11T15:27:47.488Z</lastmod><news:news><news:publication_date>2026-05-11T15:27:47.488Z</news:publication_date>
        <news:title><![CDATA[Vepdegestrant FDA Approval: What to Know About the First Breast Cancer PROTAC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-zenocutuzumab-zbco-for-advanced-unresectable-or-metastatic-cholangiocarcinoma</loc><lastmod>2026-05-08T20:17:24.282Z</lastmod><news:news><news:publication_date>2026-05-08T20:17:24.282Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/almost-half-of-older-adults-with-metastatic-nsclc-went-untreated</loc><lastmod>2026-05-08T14:22:17.698Z</lastmod><news:news><news:publication_date>2026-05-08T14:22:17.698Z</news:publication_date>
        <news:title><![CDATA[Almost Half of Older Adults With Metastatic NSCLC Went Untreated]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/wellness-in-oncology-nursing-tied-to-safety-and-outcomes</loc><lastmod>2026-05-06T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-06T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Wellness in Oncology Nursing Tied to Safety and Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/gedatolisib-combination-improves-pfs-in-pik3ca-mutant-hr-her2--breast-cancer-versus-alpelisib</loc><lastmod>2026-05-05T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-05T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Gedatolisib Combination Improves PFS in PIK3CA-Mutant HR+/HER2- Breast Cancer Versus Alpelisib]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-oks-once-daily-ruxolitinib-xr-for-mf-pv-gvhd</loc><lastmod>2026-05-04T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-04T14:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Veppanu for ESR1+ Metastatic Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/the-role-of-oncology-nurses-in-bladder-cancer-care</loc><lastmod>2026-05-01T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T20:00:00Z</news:publication_date>
        <news:title><![CDATA[The Role of Oncology Nurses in Bladder Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-vepdegestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer</loc><lastmod>2026-05-01T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T17:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Vepdegestrant for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/the-evolving-role-of-oncology-nurses-in-clinical-trials</loc><lastmod>2026-04-30T20:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T20:00:00Z</news:publication_date>
        <news:title><![CDATA[The Evolving Role of Oncology Nurses in Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/datopotamab-deruxtecan-improves-survival-outcomes-in-advanced-triple-negative-breast-cancer</loc><lastmod>2026-04-30T15:28:47.724Z</lastmod><news:news><news:publication_date>2026-04-30T15:28:47.724Z</news:publication_date>
        <news:title><![CDATA[Datopotamab Deruxtecan Improves Survival Outcomes in Advanced Triple-Negative Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/elrexfio-improves-progression-free-survival-in-multiple-myeloma-phase-3-trial</loc><lastmod>2026-04-29T15:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Elranatamab Improves Progression-Free Survival in Multiple Myeloma Phase 3 Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/protecting-the-frontline-the-evolution-of-hazardous-drug-safety-in-oncology-nursing</loc><lastmod>2026-04-29T09:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T09:00:00Z</news:publication_date>
        <news:title><![CDATA[Protecting the Frontline: The Evolution of Hazardous Drug Safety in Oncology Nursing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/paget-disease-of-the-breast-what-oncology-nurses-should-know-about-recognition-diagnosis-and-management</loc><lastmod>2026-04-28T20:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Paget Disease of the Breast: What Oncology Nurses Should Know About Recognition, Diagnosis, and Management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/daratumumab-vrd-for-newly-diagnosed-multiple-myeloma-oncology-nps-review-frontline-cd38-therapy-and-ae-management</loc><lastmod>2026-04-28T13:30:00Z</lastmod><news:news><news:publication_date>2026-04-28T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Daratumumab-VRd for Newly Diagnosed Multiple Myeloma: Oncology NPs Review Frontline CD38 Therapy and AE Management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/oncology-nurses-play-key-role-as-kras-targeted-therapies-expand-across-cancer-care</loc><lastmod>2026-04-27T21:00:00Z</lastmod><news:news><news:publication_date>2026-04-27T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Oncology Nurses Play Key Role as KRAS-Targeted Therapies Expand Across Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-accepts-sbla-for-zanidatamab-combinations-in-first-line-her2-positive-gastroesophageal-adenocarcinoma</loc><lastmod>2026-04-27T19:30:00Z</lastmod><news:news><news:publication_date>2026-04-27T19:30:00Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts sBLA for Zanidatamab Combinations in First-Line HER2-Positive Gastroesophageal Adenocarcinoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/to-freeze-or-not-to-freeze-when-is-the-question</loc><lastmod>2026-04-24T18:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T18:00:00Z</news:publication_date>
        <news:title><![CDATA[To Freeze or Not to Freeze: When Is the Question]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/alpha-dart-trial-expansion-advances-pancreatic-cancer-study</loc><lastmod>2026-04-24T14:38:43.004Z</lastmod><news:news><news:publication_date>2026-04-24T14:38:43.004Z</news:publication_date>
        <news:title><![CDATA[Alpha DaRT Trial Expansion Advances Pancreatic Cancer Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/lunresertib-combo-gains-fast-track-in-resistant-ovarian-cancer</loc><lastmod>2026-04-23T18:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Lunresertib Combo Gains Fast Track in Resistant Ovarian Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/early-recognition-and-long-term-management-of-iraes-in-oncology-nursing</loc><lastmod>2026-04-23T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Early Recognition and Long-Term Management of irAEs in Oncology Nursing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/global-oncology-gaps-highlight-barriers-to-equitable-cancer-care</loc><lastmod>2026-04-22T18:00:00Z</lastmod><news:news><news:publication_date>2026-04-22T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Global Oncology Gaps Highlight Barriers to Equitable Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ozekibart-shows-activity-in-late-line-colorectal-cancer</loc><lastmod>2026-04-22T13:25:12.700Z</lastmod><news:news><news:publication_date>2026-04-22T13:25:12.700Z</news:publication_date>
        <news:title><![CDATA[Ozekibart Shows Activity in Late-Line Colorectal Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/phase-3-litespark-012-misses-end-points-in-advanced-rcc</loc><lastmod>2026-04-21T13:43:42.271Z</lastmod><news:news><news:publication_date>2026-04-21T13:43:42.271Z</news:publication_date>
        <news:title><![CDATA[Phase 3 LITESPARK-012 Misses End Points in Advanced RCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-grants-priority-review-to-enfortumab-vedotin-plus-pembrolizumab-in-mibc</loc><lastmod>2026-04-20T17:30:24.445Z</lastmod><news:news><news:publication_date>2026-04-20T17:30:24.445Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Priority Review to Enfortumab Vedotin Plus Pembrolizumab in MIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/psychosocial-challenges-impact-young-adults-with-cancer</loc><lastmod>2026-04-20T16:31:43.068Z</lastmod><news:news><news:publication_date>2026-04-20T16:31:43.068Z</news:publication_date>
        <news:title><![CDATA[Psychosocial Challenges Impact Young Adults With Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/mocertatug-rezetecan-shows-high-orr-in-ovarian-and-endometrial-cancer</loc><lastmod>2026-04-19T20:00:00Z</lastmod><news:news><news:publication_date>2026-04-19T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Mocertatug Rezetecan Shows High ORR in Ovarian and Endometrial Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/niraparib-maintenance-shows-real-world-safety-in-ovarian-cancer</loc><lastmod>2026-04-19T13:00:00Z</lastmod><news:news><news:publication_date>2026-04-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Niraparib Maintenance Shows Real-World Safety in Ovarian Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/mirvetuximab-soravtansine-real-world-ovarian-cancer-data-matches-mirasol</loc><lastmod>2026-04-18T18:00:00Z</lastmod><news:news><news:publication_date>2026-04-18T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Mirvetuximab Soravtansine Real-World Ovarian Cancer Data Matches MIRASOL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/luts-often-underdiagnosed-in-gynecologic-cancer-survivors</loc><lastmod>2026-04-18T13:00:00Z</lastmod><news:news><news:publication_date>2026-04-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[LUTS Often Underdiagnosed in Gynecologic Cancer Survivors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/beyond-the-base-tan-why-sun-vigilance-is-vital-for-melanoma-survivors</loc><lastmod>2026-04-17T20:00:00Z</lastmod><news:news><news:publication_date>2026-04-17T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Beyond the "Base Tan": Why Sun Vigilance is Vital for Melanoma Survivors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fertility-counseling-in-breast-cancer-dr-don-dizon-on-early-referral</loc><lastmod>2026-04-17T15:42:31.820Z</lastmod><news:news><news:publication_date>2026-04-17T15:42:31.820Z</news:publication_date>
        <news:title><![CDATA[Fertility Counseling in Breast Cancer: Dr. Don Dizon on Early Referral]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-approves-alembic-pharmaceuticals-anda-for-methotrexate-injection</loc><lastmod>2026-04-16T20:27:48.236Z</lastmod><news:news><news:publication_date>2026-04-16T20:27:48.236Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Alembic Pharmaceuticals’ ANDA for Methotrexate Injection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/oral-paclitaxel-dhp107-non-inferior-to-iv-for-metastatic-breast-cancer</loc><lastmod>2026-04-16T13:55:28.426Z</lastmod><news:news><news:publication_date>2026-04-16T13:55:28.426Z</news:publication_date>
        <news:title><![CDATA[Oral Paclitaxel DHP107 Non-inferior to IV for Metastatic Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/chemo-plus-letrozole-remains-standard-for-frontline-lgsoc</loc><lastmod>2026-04-15T20:55:44.928Z</lastmod><news:news><news:publication_date>2026-04-15T20:55:44.928Z</news:publication_date>
        <news:title><![CDATA[Chemo Plus Letrozole Remains Standard for Frontline LGSOC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/abemaciclib-plus-letrozole-shows-activity-in-endometrial-carcinoma</loc><lastmod>2026-04-15T16:46:09.038Z</lastmod><news:news><news:publication_date>2026-04-15T16:46:09.038Z</news:publication_date>
        <news:title><![CDATA[Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/ons-president-jessica-mcintyre-on-app-fellows-and-survivorship</loc><lastmod>2026-04-15T09:00:00Z</lastmod><news:news><news:publication_date>2026-04-15T09:00:00Z</news:publication_date>
        <news:title><![CDATA[ONS President Jessica MacIntyre on APP Fellows and Survivorship]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/avutometinib-and-defactinib-show-durable-results-in-ovarian-cancer-study</loc><lastmod>2026-04-14T20:45:12.905Z</lastmod><news:news><news:publication_date>2026-04-14T20:45:12.905Z</news:publication_date>
        <news:title><![CDATA[Avutometinib and Defactinib Show Durable Results in Ovarian Cancer Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/relacorilant-plus-nab-paclitaxel-boosts-survival-in-ovarian-cancer</loc><lastmod>2026-04-14T13:00:00Z</lastmod><news:news><news:publication_date>2026-04-14T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Relacorilant Plus Nab-Paclitaxel Boosts Survival in Ovarian Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/darovasertib-plus-crizotinib-improves-pfs-in-metastatic-uveal-melanoma</loc><lastmod>2026-04-13T20:00:00Z</lastmod><news:news><news:publication_date>2026-04-13T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Darovasertib Plus Crizotinib Improves PFS in Metastatic Uveal Melanoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/peer-support-boosts-endometrial-cancer-care-for-black-women</loc><lastmod>2026-04-13T15:32:24.946Z</lastmod><news:news><news:publication_date>2026-04-13T15:32:24.946Z</news:publication_date>
        <news:title><![CDATA[Peer Support Boosts Endometrial Cancer Care for Black Women]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nurses-urged-to-avoid-age-based-assumptions-in-toxicity-care</loc><lastmod>2026-04-11T15:03:00Z</lastmod><news:news><news:publication_date>2026-04-11T15:03:00Z</news:publication_date>
        <news:title><![CDATA[Nurses Urged to Avoid Age-Based Assumptions in Toxicity Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/fda-accepts-nda-for-tlx101-px-imaging-agent-in-glioma</loc><lastmod>2026-04-10T17:59:41.710Z</lastmod><news:news><news:publication_date>2026-04-10T17:59:41.710Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts NDA for TLX101-Px Imaging Agent in Glioma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nurses-key-in-catching-early-io-toxicities-supporting-follow-up</loc><lastmod>2026-04-09T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-09T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Nurses Key in Catching Early IO Toxicities, Supporting Follow-Up]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/chemo-safety-program-targets-systemwide-hospital-culture-shift</loc><lastmod>2026-04-08T19:24:03.748Z</lastmod><news:news><news:publication_date>2026-04-08T19:24:03.748Z</news:publication_date>
        <news:title><![CDATA[Chemo Safety Program Targets Systemwide Hospital Culture Shift]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/gotistobart-reduces-death-risk-in-advanced-squamous-nsclc</loc><lastmod>2026-04-08T15:48:35.021Z</lastmod><news:news><news:publication_date>2026-04-08T15:48:35.021Z</news:publication_date>
        <news:title><![CDATA[Gotistobart Reduces Death Risk in Advanced Squamous NSCLC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/global-barriers-strain-oncology-nurses-in-lmics-care-delivery</loc><lastmod>2026-04-07T20:33:12.089Z</lastmod><news:news><news:publication_date>2026-04-07T20:33:12.089Z</news:publication_date>
        <news:title><![CDATA[Global Barriers Strain Oncology Nurses in LMICs Care Delivery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/nuvalent-submits-nda-for-neladalkib-in-alk-nsclc-after-tkis</loc><lastmod>2026-04-07T15:12:57.230Z</lastmod><news:news><news:publication_date>2026-04-07T15:12:57.230Z</news:publication_date>
        <news:title><![CDATA[Nuvalent Submits NDA for Neladalkib in ALK+ NSCLC After TKIs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/zongertinib-shows-activity-in-her2-mutant-nsclc-including-brain-metastases</loc><lastmod>2026-04-06T18:39:54.273Z</lastmod><news:news><news:publication_date>2026-04-06T18:39:54.273Z</news:publication_date>
        <news:title><![CDATA[Zongertinib Shows Activity in HER2-Mutant NSCLC, Including Brain Metastases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/metformin-may-mimic-exercise-signals-in-prostate-cancer-care</loc><lastmod>2026-04-06T15:29:34.369Z</lastmod><news:news><news:publication_date>2026-04-06T15:29:34.369Z</news:publication_date>
        <news:title><![CDATA[Metformin May Mimic Exercise Signals in Prostate Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/clinical-practice-updates-navigating-the-new-standard-of-care-in-bladder-cancer</loc><lastmod>2026-04-05T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-05T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.oncnursingnews.com/view/closing-the-global-equity-gap-nursing-implications-for-worldwide-cancer-care-delivery</loc><lastmod>2026-04-04T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-04T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Global Equity Gap: Nursing Implications for Worldwide Cancer Care Delivery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>